The FDA announced plans this week to move forward with a trial release of genetically modified mosquitoes in the U.S. as a strategy to fight the Zika virus. The announcement details the release of the GM male mosquitoes into the environment somewhere near Key West, Florida.
The male mosquitoes have been modified to contain a gene that kills the insect’s offspring. When the males mate with the female population, they produce offspring that die almost immediately, as the lifespan of an average mosquito is approximately two days.
The FDA has assured there will be no negative or adverse affects on human health, indigenous animal populations, or the environment.
The FDA stated the decision was reached in part to data obtained from Oxitec, the British corporation that created the mosquitoes, including a lengthy document warning of the potentially hazardous risks surrounding the insects. The FDA feels confident in their safety assurances because the GM mosquitoes will all be male and that Oxitec’s data contained “no convincing evidence” that the manipulated proteins the females will carry could cause adverse or harmful side effects. Somehow, the FDA is also confident that the mosquitoes will be unable to successfully adapt to the wild due to their short life spans.
“The consequences of escape, survival, and establishment of the mosquito in the environment have been extensively studied. Data and information from those studies indicate that there are unlikely to be any adverse effects on non-target species, including humans. Risk of establishment or spread has been determined to be negligible,” the FDA stated in the press release.
“While we didn’t expect anything different, we’re pleased the FDA has now published their data,” said Haydn Parry, CEO of Oxitec. “Now we want to get everybody comfortable with the decision.”
The FDA has announced a 30-day public commenting period beginning March 11, 2016. To submit your comments, visit www.regulations.gov and type FDA-2014-N-2235 in the search box.
To submit your comments by mail, use the following address. Make sure to include docket number FDA-2014-N-2235 on each page submitted.
The Division of Dockets Management
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852
Oxitec has already begun conducting GM mosquito trials in Piracicaba, a city in São Paulo, Brazil. The region has seen a spike in microcephaly since the genetically altered insects were released into the environment, concerning both citizens and scientists. More than 600 cases of microcephaly have been reported since last spring.
Is Microcephaly Really Caused By GM Mosquitoes?
An Argentinian environmental group, Physicians in Crop-Sprayed Towns (PCST), released a statement emphatically stating the microcephaly spike isn’t linked to Zika, after all, but a larvicide added to water in Brazil.
Ironically, the larvicide, Pyriproxyfen, is added to the water to combat the development of mosquito larvae in drinking water tanks.
“Malformations detected in thousands of children from pregnant women living in areas where the Brazilian state added pyriproxyfen to drinking water is not a coincidence, even though the Ministry of Health places a direct blame on Zika virus for this damage, while trying to ignore its responsibility and ruling out the hypothesis of direct and cumulative chemical damage caused by years of endocrine and immunological disruption of the a acted population,” PCST said.
“Previous Zika epidemics did not cause birth defects in newborns, despite infecting 75 percent of the population in those countries. Also, in other countries such as Colombia there are no records of microcephaly; however, there are plenty of Zika cases.”
The larvicide, sold commercially as SumiLarv, is manufactured by Sumitomo Chemical, a Japanese subsidiary of Monsanto.
Still, another potential cause of the microcephaly outbreak in Brazil is being blamed on a mandated Tdap vaccine that the Brazilian government began requiring for all pregnant women towards the end of 2014. The vaccine, manufactured by GlaxoSmithKline in the UK, is called Boostrix. The safety of Boostrix for pregnant women has not been determined, and only ONE safety study has ever been conducted, on pregnant rats nonetheless. GlaxoSmithKline recommends the administration of the vaccine between the 27th and 36th week of pregnancy.
The CDC is also a huge proponent of vaccinating pregnant women with an untested, potentially harmful syringe, “The guidelines state a dose of Tdap be administered during each pregnancy, regardless of the patient’s previous history of receiving Tdap.”
Curiously, The Bill and Melinda Gates Foundation donated over $300,000 to the Vanderbilt Vaccine Research Program in 2015 to study immunicological effects of the Tdap vaccine on pregnant women. Why wasn’t this kind of safety testing done before the vaccine became mandatory?
This is not the first time that a vaccine, specifically the Tetanus shot, was linked to a catastrophic outcome. During the early 1990s, Nicaragua, Mexico and the Philippines reported that vaccine vials were contaminated with hCG, causing ‘failure to maintain a pregnancy’ and sterility. Canadian vaccine manufacturers Connaught Labs and Intervex and CSL Labs from Australia were involved in the scandal.
Blaming the microcephaly outbreak in Brazil on Zika, a virus that has been around for more than six decades, instead of the absolute factor changes, like a mandated vaccine or the addition of a potent chemical in the water supply, is corrupt and unethical. We breathe air that is manipulated, we eat modified food, we are creating modified species to deal with unnecessary man-made modifications…a mosquito to kill the virus, a chemical to kill the mosquito, a cancer caused by the chemical that killed the mosquito in an attempt to protect the food…
Where does this stop? How long shall we ignore the real causes of cancers, autism, and autoimmune disorders?
Join the fight to take back our planet and pledge to March Against Monsanto on May 21, 2016. This is an international event, happening in countries and cities all over the world. Find your local event here. For questions, support, or to register a city not on the list, email email@example.com.